Systematic review of tirzepatide for adults living with obesity
BMJ Evidence-Based Medicine
2025
Study summary
Systematic review of randomized trials of tirzepatide in adults with obesity.
Peptides studied
Goals studied
Stack studied
Advanced Metabolic Stack
Key findings
The review found robust weight-loss efficacy with expected incretin-class adverse events.
Study details
Study type
systematic review
Journal
BMJ Evidence-Based Medicine
DOI / PubMed
10.1136/bmjebm-2024-113253
Year
2025
Explore peptide profiles
Discover compounds, understand their mechanisms, and explore the research behind each peptide.
